COMMUNIQUÉS West-GlobeNewswire

Emerald Health Therapeutics Announces Closing of $25 million Convertible Debenture Unit Financing
10/09/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. ("Emerald" or the " [...]
The Delta Companies’ Ty Chambers Takes On New Role as President of Client Services
10/09/2019
DALLAS, Sept. 10, 2019 (GLOBE NEWSWIRE) -- The Delta Companies (TDC), a leading healthcare staffing firm, announced that Ty Chambers has taken on the role of President of Client Services. As President of Client Services [...]
Inventiva announces the positive recommendation of the 4th and last DSMB of the Phase IIb clinical study with lanifibranor in NASH
10/09/2019
No safety issue reported and recommendation to continue the study without changing the protocol Daix (France), September 10, 2019 – Inventiva (Euronext: IVA), a clinical-stage biopharmaceutical company developing oral [...]
Inventiva annonce l’avis positif du 4ème et dernier DSMB de l’étude clinique de Phase IIb avec lanifibranor dans la NASH
10/09/2019
Aucun problème de sécurité constaté et recommandation de poursuivre l’étude sans modification du protocole Daix (France), le 10 septembre 2019 – Inventiva (Euronext : IVA), société biopharmaceutique spécialisée dans le [...]
Windsor Strategy Partners Appoints Paul Fallisi as President
10/09/2019
Founder David Wilson Will Continue as Chief Executive Officer PRINCETON, N.J., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Windsor Strategy Partners Inc., a leading health care actuarial firm, announced today that Paul Fallisi, [...]
Tauriga Sciences, Inc. Obtains Approval of its Stockholders to Increase its Authorized Common Stock at Special Shareholder Meeting
10/09/2019
New York, NY, Sept. 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]
Vaxil Announces Private Placement
10/09/2019
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Sept. 10, 2019 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“ Vaxil ” or the “ Company ”) (TSX VENTURE: VXL), an innovative immunotherapy biotech [...]
HIMSS Shares Early Achievements from “Data: Elemental to Health” Campaign
10/09/2019
HIMSS is leading a new campaign with other industry groups to support legislative efforts aimed at improving the nation’s public health data systems WASHINGTON, D.C., Sept. 10, 2019 (GLOBE NEWSWIRE) -- The Healthcare [...]
Pressure BioSciences’ PCT Platform Identified as Pivotal for Cancer Biomarker Discovery and for Potential Clinical Diagnostics
10/09/2019
Two Prestigious Research Centers Report PBI’s PCT Platform Delivers Superior Results for Protein Biomarker Discovery Studies from Preserved Cancer Biopsy Tissue Samples SOUTH EASTON, MA, Sept. 10, 2019 (GLOBE NEWSWIRE [...]
AssistRx Appoints Jan Nielsen as Division President of Patient Solutions Business
10/09/2019
Industry leader brings 30-plus years of operational and clinical expertise to growing Orlando-based company ORLANDO, Fla., Sept. 10, 2019 (GLOBE NEWSWIRE) -- AssistRx, the intelligent specialty therapy initiation and [...]
PHASTAR Names Dr. Jennifer Bradford to Head Data Science Group
10/09/2019
CAMBRIDGE, Mass. and LONDON, Sept. 10, 2019 (GLOBE NEWSWIRE) -- PHASTAR , a global CRO, announced today that Dr. Jennifer Bradford has been named to lead PHASTAR’s Data Science Group, a team of experienced scientists [...]
Innovation Pharmaceuticals Plans for Clinical Trial of Oral Brilacidin for Ulcerative Colitis Program in 4th Quarter 2019
10/09/2019
BEVERLY, Mass., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to inform shareholders that the Company is planning for [...]
Ultragenyx and Kyowa Kirin Announce Intent to Submit Supplemental Biologics License Application to U.S. FDA for Crysvita® (burosumab) in Tumor-Induced Osteomalacia (TIO)
10/09/2019
NOVATO, Calif. and TOKYO, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, and [...]
Keith Cook Named President of Comprehensive Pharmacy Services Ambulatory & Specialty Pharmacy Division
10/09/2019
CPS Expanding Specialty Pharmacy Solutions to More U.S. Hospitals Under Keith Cook’s Leadership MEMPHIS, Tenn., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Comprehensive Pharmacy Services (CPS), the nation’s largest hospital [...]
SetPoint Medical Appoints Anna Gawlicka as VP of Clinical Affairs
10/09/2019
Industry veteran brings clinical affairs experience as SetPoint expands its clinical program in rheumatoid arthritis VALENCIA, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage company [...]
EXMCeuticals Inc. provides Corporate Update
10/09/2019
VANCOUVER, British Columbia, Sept. 10, 2019 (GLOBE NEWSWIRE) -- EXMceuticals Inc. ( CSE: EXM ) ( FSE: A2PAW2 ) (the “ Company ” or “ EXM” ), a cultivator and producer of cannabis extractions and refined ingredients for [...]
Axim® Biotechnologies Begins Manufacturing Cannabinoid-Based Gum With Dronabinol for Use in Upcoming Pre-Clinical Studies
10/09/2019
NEW YORK , Sept. 10, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (“AXIM ® Biotech,” “AXIM” or “the Company”) (OTCQB: AXIM), a world leader in cannabinoid research and development, announced today that its [...]
CV Sciences, Inc. to Present and Sponsor Natural Products Expo East
10/09/2019
Company enters its 5 th year exhibiting at the nation's largest natural products trade show, offering natural health retailers show specials, one-on-one education, and a wide selection of product offerings Natural [...]
MyoKardia to Evaluate Mavacamten as an Alternative to Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Patients
10/09/2019
Planned Study Will Assess Effect of Mavacamten on the Need for SRT Among HCM Patients Referred for Invasive Procedures SOUTH SAN FRANCISCO, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), [...]

Pages